The Phenylketonuria Market Size is expected to reach USD 1121.01 Million by 2032, at a CAGR of 6.2% during the forecast period 2022 to 2032. Phenylketonuria is a rare genetic disorder that affects approximately 1 in 10,000 to 15,000 newborns worldwide. With advances in genetic testing and newborn screening programs